The co-culture of CLL and NLC triggers the release of additional survival factors (CCL7, CCL17, CCL22, soluble CD40L, IL-6, and TNFα) whose secretion is also reduced by GS-1101. The gene discussed is CCL17; the disease is B-cell chronic lymphocytic leukemia.